Correlation Between Werewolf Therapeutics and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Lyell Immunopharma, you can compare the effects of market volatilities on Werewolf Therapeutics and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Lyell Immunopharma.
Diversification Opportunities for Werewolf Therapeutics and Lyell Immunopharma
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Werewolf and Lyell is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Lyell Immunopharma
Given the investment horizon of 90 days Werewolf Therapeutics is expected to under-perform the Lyell Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, Werewolf Therapeutics is 1.74 times less risky than Lyell Immunopharma. The stock trades about -0.26 of its potential returns per unit of risk. The Lyell Immunopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 95.00 in Lyell Immunopharma on August 30, 2024 and sell it today you would lose (3.00) from holding Lyell Immunopharma or give up 3.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Werewolf Therapeutics vs. Lyell Immunopharma
Performance |
Timeline |
Werewolf Therapeutics |
Lyell Immunopharma |
Werewolf Therapeutics and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Werewolf Therapeutics and Lyell Immunopharma
The main advantage of trading using opposite Werewolf Therapeutics and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Eliem Therapeutics | Werewolf Therapeutics vs. HCW Biologics | Werewolf Therapeutics vs. RenovoRx |
Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |